Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 390

1.

Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor.

Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL.

Case Rep Nephrol. 2015;2015:821346. doi: 10.1155/2015/821346. Epub 2015 Apr 21.

2.

Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression.

Lu X, Zoller EE, Weirauch MT, Wu Z, Namjou B, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath SK, Stevens AM, Freedman BI, Tsao BP, Jacob CO, Kamen DL, Brown EE, Gilkeson GS, Alarcón GS, Reveille JD, Anaya JM, James JA, Sivils KL, Criswell LA, Vilá LM, Alarcón-Riquelme ME, Petri M, Scofield RH, Kimberly RP, Ramsey-Goldman R, Joo YB, Choi J, Bae SC, Boackle SA, Graham DC, Vyse TJ, Guthridge JM, Gaffney PM, Langefeld CD, Kelly JA, Greis KD, Kaufman KM, Harley JB, Kottyan LC.

Am J Hum Genet. 2015 May 7;96(5):731-9. doi: 10.1016/j.ajhg.2015.03.002. Epub 2015 Apr 9.

PMID:
25865496
3.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.

Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW, Langefeld CD, Hicks PJ, Ma L, Freedman BI.

Kidney Int. 2015 Apr 8. doi: 10.1038/ki.2015.105. [Epub ahead of print]

PMID:
25853335
4.

Should kidney donors be genotyped for APOL1 risk alleles?

Freedman BI, Julian BA.

Kidney Int. 2015 Apr;87(4):671-3. doi: 10.1038/ki.2015.16. No abstract available.

PMID:
25826538
5.

Apolipoprotein l1 gene variants in deceased organ donors are associated with renal allograft failure.

Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL, Palanisamy A, Reeves-Daniel AM, Divers J.

Am J Transplant. 2015 Jun;15(6):1615-22. doi: 10.1111/ajt.13223. Epub 2015 Mar 24.

PMID:
25809272
6.

Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.

Murea M, Hsu FC, Cox AJ, Hugenschmidt CE, Xu J, Adams JN, Raffield LM, Whitlow CT, Maldjian JA, Bowden DW, Freedman BI.

Nephrol Dial Transplant. 2015 Feb 26. pii: gfv030. [Epub ahead of print]

PMID:
25722384
7.

Analysis of a cardiovascular disease genetic risk score in the Diabetes Heart Study.

Raffield LM, Cox AJ, Carr JJ, Freedman BI, Hicks PJ, Langefeld CD, Hsu FC, Bowden DW.

Acta Diabetol. 2015 Feb 21. [Epub ahead of print]

PMID:
25700702
8.

Lupus risk variants in the PXK locus alter B-cell receptor internalization.

Vaughn SE, Foley C, Lu X, Patel ZH, Zoller EE, Magnusen AF, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath S, Stevens AM, Freedman BI, Tsao BP, Jacob CO, Kamen DL, Brown EE, Gilkeson GS, Alarcón GS, Reveille JD, Anaya JM, James JA, Moser KL, Criswell LA, Vilá LM, Alarcón-Riquelme ME, Petri M, Scofield RH, Kimberly RP, Ramsey-Goldman R, Binjoo Y, Choi J, Bae SC, Boackle SA, Vyse TJ, Guthridge JM, Namjou B, Gaffney PM, Langefeld CD, Kaufman KM, Kelly JA, Harley IT, Harley JB, Kottyan LC.

Front Genet. 2015 Jan 8;5:450. doi: 10.3389/fgene.2014.00450. eCollection 2014.

9.

Apolipoprotein L1-Associated Nephropathy and the Future of Renal Diagnostics.

Larsen CP, Freedman BI.

J Am Soc Nephrol. 2015 Jan 8. pii: ASN.2014101052. [Epub ahead of print] No abstract available.

PMID:
25573910
10.

Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.

Martins M, Williams AH, Comeau M, Marion M, Ziegler JT, Freedman BI, Merrill JT, Glenn SB, Kelly JA, Sivils KM, James JA, Guthridge JM, Alarcón-Riquelme ME, Bae SC, Kim JH, Kim D, Anaya JM, Boackle SA, Criswell LA, Kimberly RP, Alarcón GS, Brown EE, Vilá LM, Petri MA, Ramsey-Goldman R, Niewold TB, Tsao BP, Gilkeson GS, Kamen DL, Jacob CO, Stevens AM, Gaffney PM, Harley JB, Langefeld CD, Fesel C.

Genes Immun. 2015 Mar;16(2):142-50. doi: 10.1038/gene.2014.73. Epub 2015 Jan 8.

PMID:
25569266
11.

Heritability and genetic association analysis of neuroimaging measures in the Diabetes Heart Study.

Raffield LM, Cox AJ, Hugenschmidt CE, Freedman BI, Langefeld CD, Williamson JD, Hsu FC, Maldjian JA, Bowden DW.

Neurobiol Aging. 2015 Mar;36(3):1602.e7-15. doi: 10.1016/j.neurobiolaging.2014.11.008. Epub 2014 Nov 20.

PMID:
25523635
12.

Prediction of mortality using a multi-bed vascular calcification score in the Diabetes Heart Study.

Cox AJ, Hsu FC, Agarwal S, Freedman BI, Herrington DM, Carr JJ, Bowden DW.

Cardiovasc Diabetol. 2014 Dec 12;13:160. doi: 10.1186/s12933-014-0160-5.

13.

Prevalence and determinants of electrocardiographic abnormalities in African Americans with type 2 diabetes.

Sellers MB, Divers J, Lu L, Xu J, Smith SC, Bowden DW, Herrington D, Freedman BI, Soliman EZ.

J Epidemiol Glob Health. 2014 Dec;4(4):289-96. doi: 10.1016/j.jegh.2014.04.003. Epub 2014 May 24.

PMID:
25455646
14.

Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.

Zhang K, Mir SA, Hightower CM, Miramontes-Gonzalez JP, Maihofer AX, Chen Y, Mahata SK, Nievergelt CM, Schork NJ, Freedman BI, Vaingankar SM, O'Connor DT.

J Am Soc Nephrol. 2014 Nov 12. pii: ASN.2014060537. [Epub ahead of print]

PMID:
25392232
15.

Kidney disease and cognitive function: african american-diabetes heart study MIND.

Palmer ND, Sink KM, Smith SC, Xu J, Bowden DW, Hugenschmidt CE, Whitlow CT, Williamson JD, Maldjian JA, Divers J, Freedman BI.

Am J Nephrol. 2014;40(3):200-7. doi: 10.1159/000367669. Epub 2014 Oct 10.

PMID:
25323981
16.

A comparison of type 2 diabetes risk allele load between African Americans and European Americans.

Keaton JM, Cooke Bailey JN, Palmer ND, Freedman BI, Langefeld CD, Ng MC, Bowden DW.

Hum Genet. 2014 Dec;133(12):1487-95. doi: 10.1007/s00439-014-1486-5. Epub 2014 Oct 2.

PMID:
25273842
17.

Shroom3 contributes to the maintenance of the glomerular filtration barrier integrity.

Yeo NC, O'Meara CC, Bonomo JA, Veth KN, Tomar R, Flister MJ, Drummond IA, Bowden DW, Freedman BI, Lazar J, Link BA, Jacob HJ.

Genome Res. 2015 Jan;25(1):57-65. doi: 10.1101/gr.182881.114. Epub 2014 Oct 1.

PMID:
25273069
18.

Risk factors: familial aggregation of ESRD in Europeans-is it in the genes?

Freedman BI, Robinson TW.

Nat Rev Nephrol. 2014 Dec;10(12):677-8. doi: 10.1038/nrneph.2014.181. Epub 2014 Sep 30.

PMID:
25266211
19.

Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD.

Palmer ND, Ng MC, Langefeld CD, Divers J, Lea JP, Okusa MD, Kimberly RP, Bowden DW, Freedman BI.

J Am Soc Nephrol. 2015 May;26(5):1021-5. doi: 10.1681/ASN.2014050444. Epub 2014 Sep 23.

PMID:
25249559
20.

The kidney research national dialogue: gearing up to move forward.

Bonventre JV, Boulware LE, Dember LM, Freedman BI, Furth SL, Holzman LB, Ketchum CJ, Little MH, Mehrotra R, Moe SM, Sands JM, Sedor JR, Somlo S, Star RA, Rys-Sikora KE; Kidney Research National Dialogue (KRND).

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1806-11. doi: 10.2215/CJN.07310714. Epub 2014 Sep 15.

PMID:
25225184
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk